Observational studyInternational journal of clinical oncology2024

Financial toxicity and patient experience associated with financial burden of molecular-targeted and immune therapies for cancer: an observational study under public health insurance.

Sena Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.